SCHEMBL2013785

SCHEMBL2013785

CN(C(=O)c1ccc2ncccc2c1)C(CCNC(=O)c1cccn1C)Cc1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.67
HCRTR2 O43614 2/20 0.67
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
HTR1A P08908 1/20 0.42
ADRA2A P08913 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
ADRA1D P25100 1/20 0.42
HTR2A P28223 1/20 0.42
ADRA1A P35348 1/20 0.42
HRH1 P35367 1/20 0.42
ADRA1B P35368 1/20 0.42
DRD3 P35462 1/20 0.42
KCNH2 Q12809 1/20 0.42
CCR1 P32246 1/20 0.41
PLK1 P53350 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2013242 0.91 HCRTR1 (0.70) HCRTR1HCRTR2NPC1RAB9AALDH1A1
SCHEMBL2015950 0.91 HCRTR1 (0.70) HCRTR1HCRTR2NPC1RAB9AALDH1A1
SCHEMBL6918071 0.90 HCRTR1 (0.66) HCRTR1HCRTR2NPC1RAB9AHTR1A
SCHEMBL2013516 0.90 HCRTR1 (0.66) HCRTR1HCRTR2NPC1RAB9AHTR1A
SCHEMBL2013098 0.85 HCRTR1 (0.66) HCRTR1HCRTR2NPC1RAB9AHTR1A
SCHEMBL2013804 0.85 HCRTR1 (0.73) HCRTR1HCRTR2NPC1RAB9AHDAC1
SCHEMBL2015002 0.85 HCRTR1 (0.69) HCRTR1HCRTR2NPC1RAB9ADRD3
SCHEMBL2017845 0.85 HCRTR1 (0.68) HCRTR1HCRTR2NPC1RAB9AHDAC1
SCHEMBL2014120 0.85 HCRTR1 (0.68) HCRTR1HCRTR2NPC1RAB9AHDAC1
SCHEMBL2017387 0.85 HCRTR1 (0.71) HCRTR1HCRTR2NPC1RAB9AHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO claimed
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed